Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) issued its quarterly earnings results on Wednesday. The real estate investment trust reported $0.36 earnings per share for the quarter, meeting the consensus estimate of $0.36, Zacks reports. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.59%. The business had revenue of $182.35 million for the quarter, compared to the consensus estimate of $178.01 million. Sabra Health Care REIT updated its FY 2025 guidance to 1.430-1.460 EPS.
Sabra Health Care REIT Price Performance
Sabra Health Care REIT stock traded down $0.50 during mid-day trading on Friday, reaching $15.89. 2,553,591 shares of the company's stock traded hands, compared to its average volume of 2,069,511. The company has a market cap of $3.76 billion, a price-to-earnings ratio of 29.98, a PEG ratio of 1.99 and a beta of 1.25. The stock has a 50 day moving average of $16.85 and a two-hundred day moving average of $17.62. The company has a quick ratio of 4.16, a current ratio of 4.16 and a debt-to-equity ratio of 0.90. Sabra Health Care REIT has a 12-month low of $13.31 and a 12-month high of $20.03.
Sabra Health Care REIT Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Friday, February 14th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 7.55%. The ex-dividend date is Friday, February 14th. Sabra Health Care REIT's payout ratio is 226.42%.
Analyst Ratings Changes
Several equities analysts have weighed in on the stock. Citizens Jmp raised shares of Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a report on Tuesday, January 7th. Mizuho reaffirmed a "neutral" rating and set a $20.00 price target on shares of Sabra Health Care REIT in a report on Thursday, December 5th. JMP Securities raised shares of Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 price target on the stock in a report on Tuesday, January 7th. Finally, Truist Financial downgraded shares of Sabra Health Care REIT from a "buy" rating to a "hold" rating and lowered their price target for the company from $18.00 to $17.00 in a report on Friday, January 17th. Three investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $18.86.
Check Out Our Latest Stock Analysis on SBRA
About Sabra Health Care REIT
(
Get Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Articles
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
